Prostate Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017

  • ID: 4402003
  • Report
  • 507 pages
  • GlobalData
1 of 4

FEATURED COMPANIES

  • 3D Biomatrix LLC
  • bioMerieux S.A.
  • Emory University
  • Janssen Biotech Inc
  • Onconome, Inc.
  • Tyrian Diagnostics Ltd
  • MORE
Prostate Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017

Summary

The Medical Devices sector report, “Prostate Cancer Diagnostic Tests - Medical Devices Pipeline Assessment, 2017" provides an overview of Prostate Cancer Diagnostic Tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Prostate Cancer Diagnostic Tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by a team of industry experts.

*Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope
  • Extensive coverage of the Prostate Cancer Diagnostic Tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Prostate Cancer Diagnostic Tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved/Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment/industry
Reasons to buy
  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Prostate Cancer Diagnostic Tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product’s current stage of development, territory and estimated launch date
READ MORE
Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • 3D Biomatrix LLC
  • bioMerieux S.A.
  • Emory University
  • Janssen Biotech Inc
  • Onconome, Inc.
  • Tyrian Diagnostics Ltd
  • MORE
1 Table of Contents
2 Introduction
2.1 Prostate Cancer Diagnostic Tests Overview
3 Products under Development
3.1 Prostate Cancer Diagnostic Tests - Pipeline Products by Stage of Development
3.2 Prostate Cancer Diagnostic Tests - Pipeline Products by Territory
3.3 Prostate Cancer Diagnostic Tests - Pipeline Products by Regulatory Path
3.4 Prostate Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date
3.5 Prostate Cancer Diagnostic Tests - Ongoing Clinical Trials
4 Prostate Cancer Diagnostic Tests - Pipeline Products under Development by Companies
4.1 Prostate Cancer Diagnostic Tests Companies - Pipeline Products by Stage of Development
4.2 Prostate Cancer Diagnostic Tests - Pipeline Products by Stage of Development
5 Prostate Cancer Diagnostic Tests Companies and Product Overview
5.1 3D Biomatrix LLC Company Overview
5.2 A&G Pharmaceutical Inc Company Overview
5.3 Abnova Corp Company Overview
5.4 AccuTech LLC Company Overview
5.5 Acobiom Company Overview
5.6 Adaptive Biotechnologies Corp Company Overview
5.7 Advanced Marker Discovery SL Company Overview
5.8 Affinimark Technologies, Inc. Company Overview
5.9 AIT Austrian Institute of Technology GmbH Company Overview
5.10 Albert Ludwigs University of Freiburg Company Overview
5.11 Alere Inc Company Overview
5.12 Almac Diagnostics Ltd Company Overview
5.13 AltheaDx Inc Company Overview
5.14 Ambrilia Biopharma Inc Company Overview
5.15 Andro Diagnostics (Inactive) Company Overview
5.16 ANGLE plc Company Overview
5.17 Armune BioScience Inc Company Overview
5.18 Arno Therapeutics Inc Company Overview
5.19 Arquer Diagnostics Ltd Company Overview
5.20 Arrayit Diagnostics, Inc. Company Overview
5.21 Atturos Company Overview
5.22 Aurelium BioPharma Inc. Company Overview
5.23 Bayer HealthCare AG (Inactive) Company Overview
5.24 Baylor College of Medicine Company Overview
5.25 Beckman Coulter Inc Company Overview
5.26 BioAffinity Technologies, Inc. Company Overview
5.27 Biocare Medical LLC Company Overview
5.28 Biocrates Life Sciences AG Company Overview
5.29 BioMark Diagnostics Inc. Company Overview
5.30 bioMerieux S.A. Company Overview
5.31 Bioprognos SL Company Overview
5.32 Biosceptre International Ltd Company Overview
5.33 Biotron Ltd Company Overview
5.34 Blondin Bioscience, LLC Company Overview
5.35 Caldera Health Limited Company Overview
5.36 Cancer Research Technology Ltd Company Overview
5.37 Caris Life Sciences Inc Company Overview
5.38 Cellanyx Diagnostics, Inc. Company Overview
5.39 CellMax Life Company Overview
5.40 Cellmid Ltd Company Overview
5.41 Cepheid Company Overview
5.42 Ceres Nanosciences Inc Company Overview
5.43 ChemImage Corp Company Overview
5.44 Children's Hospital Boston Company Overview
5.45 China Sky One Medical Inc Company Overview
5.46 Chronix Biomedical Inc Company Overview
5.47 Cleveland Diagnostics Inc. Company Overview
5.48 CompanDX Ltd. Company Overview
5.49 Cornell University Company Overview
5.50 Courtagen Life Sciences Inc Company Overview
5.51 CS-Keys, Inc. (Inactive) Company Overview
5.52 Cytosystems Ltd Company Overview
5.53 Dartmouth College Company Overview
5.54 Detroit R&D, Inc. Company Overview
5.55 DiagnoCure Inc. (Inactive) Company Overview
5.56 Diaxonhit SA Company Overview
5.57 Emory University Company Overview
5.58 Epic Sciences Inc Company Overview
5.59 Epigenomics AG Company Overview
5.60 Euclid Diagnostics LLC Company Overview
5.61 Eventus Diagnostics Inc (Inactive) Company Overview
5.62 Exiqon A/S Company Overview
5.63 Exosomics Siena SpA Company Overview
5.64 Fluxion Biosciences Inc Company Overview
5.65 Fred Hutchinson Cancer Research Center Company Overview
5.66 French National Institute of Health and Medical Research Company Overview
5.67 Genomic Health Inc Company Overview
5.68 Georgia Institute of Technology Company Overview
5.69 GILUPI Nanomedizin Company Overview
5.70 GlycoZym Company Overview
5.71 Gregor Diagnostics Inc Company Overview
5.72 Guangdong Medical College Company Overview
5.73 H. Lee Moffitt Cancer Center & Research Institute Inc Company Overview
5.74 Hologic Inc Company Overview
5.75 Ikonisys Inc Company Overview
5.76 Imagion Biosystems Inc Company Overview
5.77 Immunovia AB Company Overview
5.78 Imperial College London Company Overview
5.79 InterGenetics Inc Company Overview
5.80 IRIS International Inc Company Overview
5.81 IV Diagnostics Inc Company Overview
5.82 Janssen Biotech Inc Company Overview
5.83 John Hopkins University Company Overview
5.84 KineMed Inc Company Overview
5.85 King Abdullah University of Science and Technology Company Overview
5.86 Luminor Medical Technologies Inc Company Overview
5.87 MabCure Inc. Company Overview
5.88 MacroArray Technologies LLC Company Overview
5.89 Mayo Clinic US Company Overview
5.90 MDNA Life Sciences Inc Company Overview
5.91 MDxHealth SA Company Overview
5.92 Metabolomic Technologies Inc Company Overview
5.93 Metanomics Health GmbH Company Overview
5.94 MetaStat Inc Company Overview
5.95 Micromedic Technologies Ltd Company Overview
5.96 Milagen Inc Company Overview
5.97 Minomic International Ltd Company Overview
5.98 Myriad Genetics Inc Company Overview
5.99 Nano Discovery Inc. Company Overview
5.100 Nanocytomics LLC Company Overview
5.101 NanoIVD Inc Company Overview
5.102 Nanostics Inc Company Overview
5.103 NeuroBioTex Inc Company Overview
5.104 Northwestern University Company Overview
5.105 Novel Bio-spectrum Technologies Inc (Inactive) Company Overview
5.106 Nuclea Biotechnologies Inc. (Inactive) Company Overview
5.107 Numares AG Company Overview
5.108 NuView Life Sciences Inc Company Overview
5.109 Olympia Diagnostics, Inc Company Overview
5.110 Onconome, Inc. (Inactive) Company Overview
5.111 ONCOVEDA Cancer Research Center Company Overview
5.112 OncoVista Innovative Therapies Inc Company Overview
5.113 On-Q-ity, Inc. (Inactive) Company Overview
5.114 Ontario Institute for Cancer Research Company Overview
5.115 Orion Genomics LLC Company Overview
5.116 Ortho-Clinical Diagnostics Inc Company Overview
5.117 Oryzon Genomics SA Company Overview
5.118 OTraces Inc. Company Overview
5.119 Panacea Pharmaceuticals Inc Company Overview
5.120 PharmaSeq Inc Company Overview
5.121 Precision Biologics Inc Company Overview
5.122 Predictive Biosciences Inc Company Overview
5.123 PrognosDx Health Inc Company Overview
5.124 Prostate Management Diagnostics Inc Company Overview
5.125 Protagen AG Company Overview
5.126 Proteocyte Diagnostics Inc Company Overview
5.127 ProteoMediX AG Company Overview
5.128 Proteomika Company Overview
5.129 Proveri Inc. (Inactive) Company Overview
5.130 Qiagen NV Company Overview
5.131 Quanterix Corp Company Overview
5.132 Rappaport Family Institute for Research in the Medical Science Company Overview
5.133 RiboMed Biotechnologies Inc Company Overview
5.134 Roche Diagnostics International Ltd Company Overview
5.135 Roswell Park Cancer Institute Company Overview
5.136 Siamab Therapeutics Inc Company Overview
5.137 Siemens Healthcare GmbH Company Overview
5.138 Sienna Cancer Diagnostics Ltd Company Overview
5.139 Sividon Diagnostics GmbH Company Overview
5.140 Soricimed Biopharma Inc Company Overview
5.141 Source MDx Company Overview
5.142 Stage I Diagnostics Inc Company Overview
5.143 Target Discovery Inc (Inactive) Company Overview
5.144 The University of South Australia Company Overview
5.145 Thermo Fisher Scientific Inc Company Overview
5.146 TRACON Pharmaceuticals Inc Company Overview
5.147 Tyrian Diagnostics Ltd Company Overview
5.148 University College Dublin Company Overview
5.149 University of Arizona Company Overview
5.150 University of California Los Angeles Company Overview
5.151 University of Central Florida Company Overview
5.152 University of Chicago Company Overview
5.153 University of Colorado Company Overview
5.154 University of Connecticut Company Overview
5.155 University of Gottingen Company Overview
5.156 University of Iowa Company Overview
5.157 University of Malaya Company Overview
5.158 University of Maryland Baltimore Company Overview
5.159 University of Michigan Company Overview
5.160 University of Oslo Company Overview
5.161 University of Otago Company Overview
5.162 University of South Florida Company Overview
5.163 University of Strathclyde Company Overview
5.164 University of Washington Company Overview
5.165 Uppsala University Company Overview
5.166 US Biomarkers Inc Company Overview
5.167 Vermillion Inc Company Overview
5.168 Vitatex Inc. Company Overview
5.169 Vitrimark Inc (Inactive) Company Overview
5.170 Vitruvian Biomedical Inc Company Overview
5.171 VolitionRX Ltd Company Overview
5.172 ZEUS Scientific Inc Company Overview
6 Prostate Cancer Diagnostic Tests - Recent Developments
6.1 Sep 13, 2017: HIFU for Prostate Cancer now Available at North Carolina Specialty Hospital in Durham, North Carolina
6.2 Sep 06, 2017: MDxHealth Prepares for Growth with Executive Team Expansion
6.3 Sep 06, 2017: Sandra Cole Appointed Vice President and Chief Compliance Officer for OPKO's BioReference Laboratories
6.4 Sep 01, 2017: Aeterna Zentaris Announces Departure of Vice President, Finance & Chief Accounting Officer
6.5 Aug 31, 2017: MDxHealth Announces First Half 2017 Financial Results
6.6 Aug 31, 2017: EDAP Partners with Leading US HIFU provider, Vituro Health Adds Ablatherm Robotic HIFU
6.7 Aug 31, 2017: Sienna Cancer Diagnostics: Appendix 4E & 2017 Financial Report Release
6.8 Aug 30, 2017: bioMerieux - First-Half 2017 Results
6.9 Aug 24, 2017: AroCell: Interim report, Q2 2017
6.10 Aug 24, 2017: New imaging technique spots prostate tumours starved of oxygen
6.11 Aug 22, 2017: Blood Test Predicts Prostate Tumor Resistance
6.12 Aug 22, 2017: Volition Signs Agreement with the Institute of Laboratory Medicine of the Technical University of Munich, Germany, to assist in securing large trials in a range of cancers
6.13 Aug 17, 2017: Victoria Laughman Named Executive Vice President of Sales for OPKO's BioReference Laboratories
6.14 Aug 16, 2017: Dr. Jatin P. Shah, International Leader in Head and Neck Surgery, joins Proteocyte Diagnostics’ Clinical Advisory Board
6.15 Aug 15, 2017: GeneNews Announces Q2-2017 Financial Results & Provides Progress Update
6.16 Aug 14, 2017: Cancer Genetics Announces Second Quarter 2017 Financial Results, Accretive Acquisition and Capital Raise
6.17 Aug 10, 2017: ConfirmMDx Study Provides Further Validation of Epigenetic Risk Profile
6.18 Aug 10, 2017: Biocept Reports Second Quarter 2017 Financial Results
6.19 Aug 10, 2017: Aeterna Zentaris Reports Second Quarter 2017 Financial and Operating Results
6.20 Aug 09, 2017: Geron Reports Second Quarter 2017 Financial Results
6.21 Aug 09, 2017: VolitionRx Announces Second Quarter 2017 Financial Results and Business Update
6.22 Aug 08, 2017: MDxHealth Announces Service Agreement with Kaiser Southern California Permanente Medical Group
6.23 Aug 08, 2017: OPKO Health Reports Second Quarter 2017 Business and Financial Results
6.24 Aug 07, 2017: MDxHealth Appoints Seasoned EVP to Lead Sales Force Expansion
6.25 Aug 07, 2017: First Human Application of Novel PET Tracer for Prostate Cancer
6.26 Aug 03, 2017: Exosome Diagnostics Achieves ISO 13485 Certification
6.27 Aug 02, 2017: Hologic Announces Financial Results for Third Quarter of Fiscal 2017
6.28 Aug 01, 2017: Genomic Health Announces Second Quarter 2017 Financial Results and Reports Recent Business Progress
6.29 Aug 01, 2017: Exosome Diagnostics Announces New World Headquarters and Laboratory in Waltham, MA
6.30 Jul 28, 2017: ORYZON Reports Financial Results and Corporate Update for the 1st Half Ended June 30, 2017
6.31 Jul 27, 2017: Adaptive Biotechnologies Expands Leadership to Bolster Integration of Immune Profiling into Clinical Care Setting
6.32 Jul 27, 2017: Ipsen Delivers Strong Sales Growth of 18.8% in the First Half of 2017 and Upgrades Its Guidance for Full Year 2017
6.33 Jul 27, 2017: QIAGEN Reports Results for Second Quarter and First Half of 2017
6.34 Jul 25, 2017: Quest Diagnostics Reports Second Quarter 2017 Financial Results, Raises 2017 Financial Outlook
6.35 Jul 25, 2017: NeoGenomics Reports Record Revenue of $66.1 Million on 16% Volume Growth and 13% Reduction in Average Cost per Test in the Second Quarter of 2017
6.36 Jul 20, 2017: bioMerieux - Second-Quarter 2017 Business Review
6.37 Jul 20, 2017: Aeterna Zentaris Forms Strategic Review Committee and Appoints Michael Ward as CEO
6.38 Jul 18, 2017: Minomic Launches US Prospective Study of MiCheck Prostate Cancer Test
6.39 Jul 18, 2017: Johnson & Johnson Reports 2017 Second-Quarter Results
6.40 Jul 18, 2017: Quanterix Boosts Investments in its Accelerator Lab to Support Rapid Growth of Simoa Technology
6.41 Jul 10, 2017: Novus Therapeutics Announces Change in Management
6.42 Jul 06, 2017: Epigenomics issues change in guidance for financial year 2017
7 Appendix
7.1 Methodology
7.2 About
7.3 Contact
7.4 Disclaimer

List of Tables
Table 1: Prostate Cancer Diagnostic Tests - Pipeline Products by Stage of Development
Table 2: Prostate Cancer Diagnostic Tests - Pipeline Products by Territory
Table 3: Prostate Cancer Diagnostic Tests - Pipeline Products by Regulatory Path
Table 4: Prostate Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date
Table 5: Prostate Cancer Diagnostic Tests - Ongoing Clinical Trials
Table 6: Prostate Cancer Diagnostic Tests Companies - Pipeline Products by Stage of Development
Table 7: Prostate Cancer Diagnostic Tests - Pipeline Products by Stage of Development
Table 8: 3D Biomatrix LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 9: 3D Cell Assay - Metastatic Prostate Cancer - Product Status
Table 10: 3D Cell Assay - Metastatic Prostate Cancer - Product Description
Table 11: A&G Pharmaceutical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 12: Companion Diagnostic Test - Prostate Cancer - Product Status
Table 13: Companion Diagnostic Test - Prostate Cancer - Product Description
Table 14: Abnova Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 15: Biomarker Test - Prostate Cancer - Product Status
Table 16: Biomarker Test - Prostate Cancer - Product Description
Table 17: AccuTech LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 18: PSA Test - Product Status
Table 19: PSA Test - Product Description
Table 20: Acobiom Pipeline Products & Ongoing Clinical Trials Overview
Table 21: Companion Diagnostic Assay - Prostate Cancer - Product Status
Table 22: Companion Diagnostic Assay - Prostate Cancer - Product Description
Table 23: Adaptive Biotechnologies Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 24: Ipilimumab Based Companion Diagnostic Test - Product Status
Table 25: Ipilimumab Based Companion Diagnostic Test - Product Description
Table 26: Advanced Marker Discovery SL Pipeline Products & Ongoing Clinical Trials Overview
Table 27: 2nd Generation Prostate Cancer Test - Product Status
Table 28: 2nd Generation Prostate Cancer Test - Product Description
Table 29: 3rd Generation Prostate Cancer Test - Product Status
Table 30: 3rd Generation Prostate Cancer Test - Product Description
Table 31: 4th Generation Prostate Cancer Test - Product Status
Table 32: 4th Generation Prostate Cancer Test - Product Description
Table 33: Prognostic Test - Prostate Cancer - Product Status
Table 34: Prognostic Test - Prostate Cancer - Product Description
Table 35: Urine Based Diagnostic Test - Prostate Cancer - Product Status
Table 36: Urine Based Diagnostic Test - Prostate Cancer - Product Description
Table 37: Affinimark Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 38: Prostalent Diagnostic Test - Product Status
Table 39: Prostalent Diagnostic Test - Product Description
Table 40: AIT Austrian Institute of Technology GmbH Pipeline Products & Ongoing Clinical Trials Overview
Table 41: Biomarker Assay - Prostate Cancer - Product Status
Table 42: Biomarker Assay - Prostate Cancer - Product Description
Table 43: Albert Ludwigs University of Freiburg Pipeline Products & Ongoing Clinical Trials Overview
Table 44: Urine Based Non-Invasive Prostate Cancer Assay - Product Status
Table 45: Urine Based Non-Invasive Prostate Cancer Assay - Product Description
Table 46: Alere Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 47: NMP48 Test - Product Status
Table 48: NMP48 Test - Product Description
Table 49: Almac Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 50: Prostate Cancer Metastatic Assay - Product Status
Table 51: Prostate Cancer Metastatic Assay - Product Description
Table 52: AltheaDx Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 53: Prognostic Assay - Prostate Cancer - Product Status
Table 54: Prognostic Assay - Prostate Cancer - Product Description
Table 55: Ambrilia Biopharma Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 56: PSP94 Immunoassay - Product Status
Table 57: PSP94 Immunoassay - Product Description
Table 58: Andro Diagnostics (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 59: Diagnostic Test - Prostate Cancer - Product Status
Table 60: Diagnostic Test - Prostate Cancer - Product Description
Table 61: ANGLE plc Pipeline Products & Ongoing Clinical Trials Overview
Table 62: Parsortix-Based Test - Prostate Cancer - Product Status
Table 63: Parsortix-Based Test - Prostate Cancer - Product Description
Table 64: Armune BioScience Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 65: Diagnostic Test - Prostate Cancer - Product Status
Table 66: Diagnostic Test - Prostate Cancer - Product Description
Table 67: Arno Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 68: Onapristone Companion Diagnostic Assay - Prostate Cancer - Product Status
Table 69: Onapristone Companion Diagnostic Assay - Prostate Cancer - Product Description
Table 70: Arquer Diagnostics Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 71: UroSens Mcm5-ELISA Diagnostic Test - Prostate Cancer - Product Status
Table 72: UroSens Mcm5-ELISA Diagnostic Test - Prostate Cancer - Product Description
Table 73: Arquer Diagnostics Ltd - Ongoing Clinical Trials Overview
Table 74: UroSens Mcm5-ELISA Diagnostic Test - Prostate Cancer - Study of Arquer’s Mcm5-ELISA Test for Prostate Cancer
Table 75: Arrayit Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 76: Microarray-Based Diagnostic Test - Prostate Cancer - Product Status
Table 77: Microarray-Based Diagnostic Test - Prostate Cancer - Product Description
Table 78: Atturos Pipeline Products & Ongoing Clinical Trials Overview
Table 79: OCProDx - Product Status
Table 80: OCProDx - Product Description
Table 81: Aurelium BioPharma Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 82: Prostate Cancer Screening Test - Product Status
Table 83: Prostate Cancer Screening Test - Product Description
Table 84: Bayer HealthCare AG (Inactive) Pipeline Products & Ongoing Clinical Trials Overview
Table 85: ODM-201 Based Companion Diagnostic Assay - Product Status
Table 86: ODM-201 Based Companion Diagnostic Assay - Product Description
Table 87: PSMA BiTE Antibody Based Companion Diagnostic Assay - Product Status
Table 88: PSMA BiTE Antibody Based Companion Diagnostic Assay - Product Description
Table 89: Baylor College of Medicine Pipeline Products & Ongoing Clinical Trials Overview
Table 90: Diagnostic Assay - Prostate Cancer - Product Status
Table 91: Diagnostic Assay - Prostate Cancer - Product Description
Table 92: Beckman Coulter Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 93: UniCel DxC 600i Synchron Access BPH-A Assay - Product Status
Table 94: UniCel DxC 600i Synchron Access BPH-A Assay - Product Description
Table 95: BioAffinity Technologies, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 96: CyPath Diagnostic Assay - Prostate Cancer - Product Status
Table 97: CyPath Diagnostic Assay - Prostate Cancer - Product Description
Table 98: Biocare Medical LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 99: Clear View - Prostate Cancer - Product Status
Table 100: Clear View - Prostate Cancer - Product Description
Table 101: Biocrates Life Sciences AG Pipeline Products & Ongoing Clinical Trials Overview
Table 102: Metabolomic Biomarker Assay - Prostate Cancer - Product Status
Table 103: Metabolomic Biomarker Assay - Prostate Cancer - Product Description
Table 104: BioMark Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 105: Metabolomics-based Diagnostic Assay - Prostate Cancer - Product Status
Table 106: Metabolomics-based Diagnostic Assay - Prostate Cancer - Product Description
Table 107: bioMerieux S.A. Pipeline Products & Ongoing Clinical Trials Overview
Table 108: Annexin A3 Prostate Cancer Marker - Product Status
Table 109: Annexin A3 Prostate Cancer Marker - Product Description
Table 110: Companion Diagnostic Test - Hormone-Dependent Prostate Cancer - Product Status
Table 111: Companion Diagnostic Test - Hormone-Dependent Prostate Cancer - Product Description
Table 112: Diagnostic Assay - Prostate Cancer - Product Status
Table 113: Diagnostic Assay - Prostate Cancer - Product Description
Table 114: Bioprognos SL Pipeline Products & Ongoing Clinical Trials Overview
Table 115: MBDAA Prostate Cancer Test - Product Status
Table 116: MBDAA Prostate Cancer Test - Product Description
Table 117: Biosceptre International Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 118: Prostate Cancer IHC Diagnostic Test - Product Status
Table 119: Prostate Cancer IHC Diagnostic Test - Product Description
Table 120: Biotron Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 121: C-Test - Prostrate Cancer - Product Status
Table 122: C-Test - Prostrate Cancer - Product Description
Table 123: Blondin Bioscience, LLC Pipeline Products & Ongoing Clinical Trials Overview
Table 124: FACT Assay - Metastatic Prostate Cancer - Product Status
Table 125: FACT Assay - Metastatic Prostate Cancer - Product Description
Table 126: Caldera Health Limited Pipeline Products & Ongoing Clinical Trials Overview
Table 127: ProscaNZ - Product Status
Table 128: ProscaNZ - Product Description
Table 129: Cancer Research Technology Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 130: IHC Based Test - Prostate Cancer - Product Status
Table 131: IHC Based Test - Prostate Cancer - Product Description
Table 132: Caris Life Sciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 133: Diagnostic Test - PSA - Product Status
Table 134: Diagnostic Test - PSA - Product Description
Table 135: Cellanyx Diagnostics, Inc. Pipeline Products & Ongoing Clinical Trials Overview
Table 136: Cellanyx Test - Prostate Cancer - Product Status
Table 137: Cellanyx Test - Prostate Cancer - Product Description
Table 138: Cellanyx Diagnostics, Inc. - Ongoing Clinical Trials Overview
Table 139: Cellanyx Test - Prostate Cancer - A Novel Live Cell Microfluidic Diagnostic Using Phenotypic Biomarkers with Objective Algorithmic Analysis for Prostate Cancer Risk Stratification
Table 140: CellMax Life Pipeline Products & Ongoing Clinical Trials Overview
Table 141: Cellmax - Prostate Cancer - Product Status
Table 142: Cellmax - Prostate Cancer - Product Description
Table 143: Cellmid Ltd Pipeline Products & Ongoing Clinical Trials Overview
Table 144: MK-ELISA Assay - Prostate Cancer - Product Status
Table 145: MK-ELISA Assay - Prostate Cancer - Product Description
Table 146: Cepheid Pipeline Products & Ongoing Clinical Trials Overview
Table 147: Xpert Prostate CA Early Detection Test - Product Status
Table 148: Xpert Prostate CA Early Detection Test - Product Description
Table 149: Xpert Prostate Cancer Recurrence Risk Test - Product Status
Table 150: Xpert Prostate Cancer Recurrence Risk Test - Product Description
Table 151: Ceres Nanosciences Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 152: Nanotrap Prostate Cancer Biomarker Test - Product Status
Table 153: Nanotrap Prostate Cancer Biomarker Test - Product Description
Table 154: ChemImage Corp Pipeline Products & Ongoing Clinical Trials Overview
Table 155: Prognostic Test - Prostate Cancer - Product Status
Table 156: Prognostic Test - Prostate Cancer - Product Description
Table 157: Children's Hospital Boston Pipeline Products & Ongoing Clinical Trials Overview
Table 158: Collagen XXIII Biomarker Assay - Prostate Cancer - Product Status
Table 159: Collagen XXIII Biomarker Assay - Prostate Cancer - Product Description
Table 160: China Sky One Medical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 161: Diagnostic Kit - Human Prostate Specific Antigen - Product Status
Table 162: Diagnostic Kit - Human Prostate Specific Antigen - Product Description
Table 163: Chronix Biomedical Inc Pipeline Products & Ongoing Clinical Trials Overview
Table 164: Companion Diagnostic Test - Prostate Cancer - Product Status
Table 165: Companion Diagnostic Test - Prostate Cancer - Product Description
Table 166: Cleveland Diagnostics Inc. Pipeline Products & Ongoing Clinical Trials Overview

List of Figures
Figure 1: Prostate Cancer Diagnostic Tests - Pipeline Products by Stage of Development
Figure 2: Prostate Cancer Diagnostic Tests - Pipeline Products by Territory
Figure 3: Prostate Cancer Diagnostic Tests - Pipeline Products by Regulatory Path
Figure 4: Prostate Cancer Diagnostic Tests - Pipeline Products by Estimated Approval Date
Figure 5: Prostate Cancer Diagnostic Tests - Ongoing Clinical Trials
Note: Product cover images may vary from those shown
3 of 4

Loading
LOADING...

4 of 4
  • 3D Biomatrix LLC
  • A&G Pharmaceutical Inc
  • Abnova Corp
  • AccuTech LLC
  • Acobiom
  • Adaptive Biotechnologies Corp
  • Advanced Marker Discovery SL
  • Affinimark Technologies, Inc.
  • AIT Austrian Institute of Technology GmbH
  • Albert Ludwigs University of Freiburg
  • Alere Inc
  • Almac Diagnostics Ltd
  • AltheaDx Inc
  • Ambrilia Biopharma Inc
  • Andro Diagnostics
  • ANGLE plc
  • Armune BioScience Inc
  • Arno Therapeutics Inc
  • Arquer Diagnostics Ltd
  • Arrayit Diagnostics, Inc.
  • Atturos
  • Aurelium BioPharma Inc.
  • Bayer HealthCare AG
  • Baylor College of Medicine
  • Beckman Coulter Inc
  • BioAffinity Technologies, Inc.
  • Biocare Medical LLC
  • Biocrates Life Sciences AG
  • BioMark Diagnostics Inc.
  • bioMerieux S.A.
  • Bioprognos SL
  • Biosceptre International Ltd
  • Biotron Ltd
  • Blondin Bioscience, LLC
  • Caldera Health Limited
  • Cancer Research Technology Ltd
  • Caris Life Sciences Inc
  • Cellanyx Diagnostics, Inc.
  • CellMax Life
  • Cellmid Ltd
  • Cepheid
  • Ceres Nanosciences Inc
  • ChemImage Corp
  • Children's Hospital Boston
  • China Sky One Medical Inc
  • Chronix Biomedical Inc
  • Cleveland Diagnostics Inc.
  • CompanDX Ltd.
  • Cornell University
  • Courtagen Life Sciences Inc
  • CS-Keys, Inc.
  • Cytosystems Ltd
  • Dartmouth College
  • Detroit R&D, Inc.
  • DiagnoCure Inc.
  • Diaxonhit SA
  • Emory University
  • Epic Sciences Inc
  • Epigenomics AG
  • Euclid Diagnostics LLC
  • Eventus Diagnostics Inc
  • Exiqon A/S
  • Exosomics Siena SpA
  • Fluxion Biosciences Inc
  • Fred Hutchinson Cancer Research Center
  • French National Institute of Health and Medical Research
  • Genomic Health Inc
  • Georgia Institute of Technology
  • GILUPI Nanomedizin
  • GlycoZym
  • Gregor Diagnostics Inc
  • Guangdong Medical College
  • H. Lee Moffitt Cancer Center & Research Institute Inc
  • Hologic Inc
  • Ikonisys Inc
  • Imagion Biosystems Inc
  • Immunovia AB
  • Imperial College London
  • InterGenetics Inc
  • IRIS International Inc
  • IV Diagnostics Inc
  • Janssen Biotech Inc
  • John Hopkins University
  • KineMed Inc
  • King Abdullah University of Science and Technology
  • Luminor Medical Technologies Inc
  • MabCure Inc.
  • MacroArray Technologies LLC
  • Mayo Clinic US
  • MDNA Life Sciences Inc
  • MDxHealth SA
  • Metabolomic Technologies Inc
  • Metanomics Health GmbH
  • MetaStat Inc
  • Micromedic Technologies Ltd
  • Milagen Inc
  • Minomic International Ltd
  • Myriad Genetics Inc
  • Nano Discovery Inc.
  • Nanocytomics LLC
  • NanoIVD Inc
  • Nanostics Inc
  • NeuroBioTex Inc
  • Northwestern University
  • Novel Bio-spectrum Technologies Inc
  • Nuclea Biotechnologies Inc.
  • Numares AG
  • NuView Life Sciences Inc
  • Olympia Diagnostics, Inc
  • Onconome, Inc.
  • ONCOVEDA Cancer Research Center
  • OncoVista Innovative Therapies Inc
  • On-Q-ity, Inc.
  • Ontario Institute for Cancer Research
  • Orion Genomics LLC
  • Ortho-Clinical Diagnostics Inc
  • Oryzon Genomics SA
  • OTraces Inc.
  • Panacea Pharmaceuticals Inc
  • PharmaSeq Inc
  • Precision Biologics Inc
  • Predictive Biosciences Inc
  • PrognosDx Health Inc
  • Prostate Management Diagnostics Inc
  • Protagen AG
  • Proteocyte Diagnostics Inc
  • ProteoMediX AG
  • Proteomika
  • Proveri Inc.
  • Qiagen NV
  • Quanterix Corp
  • Rappaport Family Institute for Research in the Medical Science
  • RiboMed Biotechnologies Inc
  • Roche Diagnostics International Ltd
  • Roswell Park Cancer Institute
  • Siamab Therapeutics Inc
  • Siemens Healthcare GmbH
  • Sienna Cancer Diagnostics Ltd
  • Sividon Diagnostics GmbH
  • Soricimed Biopharma Inc
  • Source MDx
  • Stage I Diagnostics Inc
  • Target Discovery Inc
  • The University of South Australia
  • Thermo Fisher Scientific Inc
  • TRACON Pharmaceuticals Inc
  • Tyrian Diagnostics Ltd
  • University College Dublin
  • University of Arizona
  • University of California Los Angeles
  • University of Central Florida
  • University of Chicago
  • University of Colorado
  • University of Connecticut
  • University of Gottingen
  • University of Iowa
  • University of Malaya
  • University of Maryland Baltimore
  • University of Michigan
  • University of Oslo
  • University of Otago
  • University of South Florida
  • University of Strathclyde
  • University of Washington
  • Uppsala University
  • US Biomarkers Inc
  • Vermillion Inc
  • Vitatex Inc.
  • Vitrimark Inc
  • Vitruvian Biomedical Inc
  • VolitionRX Ltd
  • ZEUS Scientific Inc
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown
Adroll
adroll